| Product Code: ETC7663699 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Thyroid Cancer Drug Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Thyroid Cancer Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Thyroid Cancer Drug Market - Industry Life Cycle |
3.4 Israel Thyroid Cancer Drug Market - Porter's Five Forces |
3.5 Israel Thyroid Cancer Drug Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Thyroid Cancer Drug Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 Israel Thyroid Cancer Drug Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Israel Thyroid Cancer Drug Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Israel Thyroid Cancer Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of thyroid cancer in Israel |
4.2.2 Growing awareness about early detection and treatment of thyroid cancer |
4.2.3 Advancements in medical technology leading to better diagnostic and treatment options |
4.3 Market Restraints |
4.3.1 Stringent regulatory approval processes for new thyroid cancer drugs in Israel |
4.3.2 High cost associated with innovative thyroid cancer treatments |
4.3.3 Limited accessibility to specialized healthcare facilities in certain regions of Israel |
5 Israel Thyroid Cancer Drug Market Trends |
6 Israel Thyroid Cancer Drug Market, By Types |
6.1 Israel Thyroid Cancer Drug Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Thyroid Cancer Drug Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Thyroid Cancer Drug Market Revenues & Volume, By Papillary Thyroid Cancer, 2021- 2031F |
6.1.4 Israel Thyroid Cancer Drug Market Revenues & Volume, By Follicular Thyroid Cancer, 2021- 2031F |
6.1.5 Israel Thyroid Cancer Drug Market Revenues & Volume, By Hurthle Cell Cancer, 2021- 2031F |
6.1.6 Israel Thyroid Cancer Drug Market Revenues & Volume, By Medullary Thyroid Cancer (MTC), 2021- 2031F |
6.1.7 Israel Thyroid Cancer Drug Market Revenues & Volume, By Anaplastic Thyroid Cancer, 2021- 2031F |
6.2 Israel Thyroid Cancer Drug Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Thyroid Cancer Drug Market Revenues & Volume, By Thyroid Desiccated, 2021- 2031F |
6.2.3 Israel Thyroid Cancer Drug Market Revenues & Volume, By Sorafenib, 2021- 2031F |
6.2.4 Israel Thyroid Cancer Drug Market Revenues & Volume, By Thyrotropin Alfa, 2021- 2031F |
6.2.5 Israel Thyroid Cancer Drug Market Revenues & Volume, By Vandetanib, 2021- 2031F |
6.2.6 Israel Thyroid Cancer Drug Market Revenues & Volume, By Doxorubicin, 2021- 2031F |
6.2.7 Israel Thyroid Cancer Drug Market Revenues & Volume, By Cabozantinib, 2021- 2031F |
6.2.8 Israel Thyroid Cancer Drug Market Revenues & Volume, By Sodium Iodide I-131, 2021- 2031F |
6.2.9 Israel Thyroid Cancer Drug Market Revenues & Volume, By Sodium Iodide I-131, 2021- 2031F |
6.2.10 Israel Thyroid Cancer Drug Market Revenues & Volume, By Dabrafenib, 2021- 2031F |
6.3 Israel Thyroid Cancer Drug Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Israel Thyroid Cancer Drug Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Israel Thyroid Cancer Drug Market Revenues & Volume, By Injectable, 2021- 2031F |
6.3.4 Israel Thyroid Cancer Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Thyroid Cancer Drug Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Israel Thyroid Cancer Drug Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Israel Thyroid Cancer Drug Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Israel Thyroid Cancer Drug Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Israel Thyroid Cancer Drug Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Thyroid Cancer Drug Market Import-Export Trade Statistics |
7.1 Israel Thyroid Cancer Drug Market Export to Major Countries |
7.2 Israel Thyroid Cancer Drug Market Imports from Major Countries |
8 Israel Thyroid Cancer Drug Market Key Performance Indicators |
8.1 Rate of adoption of new thyroid cancer treatments in Israel |
8.2 Patient survival rates post-treatment for thyroid cancer in Israel |
8.3 Investment in research and development of thyroid cancer drugs in Israel |
9 Israel Thyroid Cancer Drug Market - Opportunity Assessment |
9.1 Israel Thyroid Cancer Drug Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Thyroid Cancer Drug Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.3 Israel Thyroid Cancer Drug Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Israel Thyroid Cancer Drug Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Israel Thyroid Cancer Drug Market - Competitive Landscape |
10.1 Israel Thyroid Cancer Drug Market Revenue Share, By Companies, 2024 |
10.2 Israel Thyroid Cancer Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here